106
Views
4
CrossRef citations to date
0
Altmetric
Original Research

QT and P-wave dispersion during the manic phase of bipolar disorder

, , , &
Pages 1805-1811 | Published online: 03 Jul 2019

References

  • Eroğlu Zengin M, Özpoyraz N. Long term treatment in bipolar bisorder. Curr Approaches Psychiatry. 2010;2(2):206–236.
  • Young AH, Grunze H. Physical health of patients with bipolar disorder. Acta Psychiatr Scand Suppl. 2013;442:3–10. doi:10.1111/acps.12117
  • Coello K, Kjærstad HL, Stanislaus S, et al. Thirty-year cardiovascular risk score in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives. Aust N Z J Psychiatry. 2018;5:4867418815987 Epub ahead of print.
  • Goldstein BI, Schaffer A, Wang S, et al. Excessive and premature new-onset cardiovascular disease among adults with bipolar disorder in the US NESARC cohort. J Clin Psychiatry. 2015;76(2):163–169. doi:10.4088/JCP.14m0930025742203
  • Westman J, Hallgren J, Wahlbeck K, et al. Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden. BMJ Open. 2013;3(4):e002373. doi:10.1136/bmjopen-2012-002373
  • Murray DP, Weiner M, Prabhakar M, Fiedorowicz JG. Mania and mortality: why the excess cardiovascular risk in bipolar disorder? Curr Psychiatry Rep. 2009;11(6):475–480.19909670
  • Wazen GLL, Gregório ML, Kemp AH, Godoy MF. Heart rate variability in patients with bipolar disorder: from mania to euthymia. J Psychiatr Res. 2018;99:33–38. doi:10.1016/j.jpsychires.2018.01.00829407285
  • Fiedorowicz JG, Solomon DA, Endicott J, et al. Manic/hypomanic symptom burden predicts cardiovascular mortality with bipolar disorder in the collaborative depression study. Psychosom Med. 2009;71(6):598–606. doi:10.1097/PSY.0b013e3181acee2619561163
  • Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34–38 years. J Affect Disord. 2002;68(2–3):167–181. doi:10.1016/S0165-0327(01)00377-912063145
  • Osby U, Brandt L, Correia N, et al. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001;58(9):844–850. doi:10.1001/archpsyc.58.9.84411545667
  • Iacono WG, Lykken DT, Peloquin LJ, Lumry AE, Valentine RH, Tuason VB. Electrodermal activity in euthymic unipolar and bipolar affective disorders: a possible marker for depression. Arch Gen Psychiatry. 1983;40(5):557–565. doi:10.1001/archpsyc.1983.017900500830106838333
  • Lake CR, Pickar D, Ziegler MG, Lipper S, Slater S, Murphy DL. High plasma norepinephrine levels in patients with major affective disorder. Am J Psychiatry. 1982;139(10):1315–1318. doi:10.1176/ajp.139.10.13156289682
  • Goodwin FK, Ghaemi SN. Understanding manic-depressive illness. Arch Gen Psychiatry. 1998;55:23–25. doi:10.1001/archpsyc.55.1.239435756
  • Zahn TP, Nurnberger JI Jr, Berrettini WH. Electrodermal activity in young adults at genetic risk for affective disorder. Arch Gen Psychiatry. 1989;46(12):1120–1124. doi:10.1001/archpsyc.1989.018101200620102589926
  • Chang HA, Chang CC, Tzeng NS, Kuo TB, Lu RB, Huang SY. Heart rate variability in unmedicated patients with bipolar disorder in the manic phase. Psychiatry Clin Neurosci. 2014;68(9):674–682. doi:10.1111/pcn.1217824612182
  • Tosu AR, Demir S, Yüksel Kaya MS, et al. Increased QT dispersion and P wave dispersion in major depressive disorder. Exp Clin Cardiol. 2013;18(2):110–112.23940433
  • Atmaca M, Yavuzkir M, Izci F, et al. QT wave dispersion in patients with panic disorder. Neurosci Bull. 2012;28(3):247–252. doi:10.1007/s12264-012-1237-322622824
  • Yavuzkir MF, Atmaca M, Gurok MG, et al. P wave dispersion in obsessive-compulsive disorder. Indian J Psychiatry. 2015;57(2):196–199. doi:10.4103/0019-5545.15819326124527
  • Izci F, Hocagil H, Izci S, Izci V, Koc MI, Acar RD. P-wave and QT dispersion in patients with conversion disorder. Ther Clin Risk Manag. 2015;26(11):475–480. doi:10.2147/TCRM.S81852
  • Atmaca M, Korkmaz H, Korkmaz SP. wave dispersion in patients with hypochondriasis. Neurosci Lett. 2010;485(3):148–150. doi:10.1056/NEJMra04343020813155
  • Tran H, White CM, Chow MS, Kluger J. An evaluation of the impact of gender and age on QT dispersion in healthy subjects. Ann Noninvasive Electrocardiol. 2001;6(2):129–133.11333170
  • Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol. 2000;36(6):1749–1766.11092641
  • Perzanowski C, Ho AT, Jacobson AK. Increased P-wave dispersion predicts recurrent atrial fibrillation after cardioversion. J Electrocardiol. 2005;38:43–46. doi:10.1016/j.jelectrocard.2004.09.00815660346
  • Schocken K. The analysis of the normal QT interval. Exp Med Surg. 1955;13(3):258–260.13262065
  • Davies LG, Ross IP. Abnormal P waves and paroxysmal tachycardia. Br Heart J. 1963;25(5):570–574. doi:10.1136/hrt.25.5.57014063002
  • Friedman BH, Thayer JF. Anxiety and autonomic flexibility: a cardiovascular approach. Biol Psychol. 1998;49(3):303–323.9858059
  • Snoeck J, Decoster H, Vrints C, et al. Predictive value of the P wave at implantation for atrial fibrillation after VVI pacemaker implantation. Pacing Clin Electrophysiol. 1992;15(11):2077–2083.1279603
  • Waggoner AD, Adyanthaya AV, Quinones MA, Alexander JK. Left atrial enlargement. Echocardiographic assessment of electrocardiographic criteria. Circulation. 1976;54(4):553–557.134852
  • Robyns T, Willems R, Vandenberk B, et al. Individualized corrected QT interval is superior to QT interval corrected using the Bazett formula in predicting mutation carriage in families with long QT syndrome. Heart Rhythm. 2017;14(3):376–382. doi:10.1016/j.hrthm.2017.06.01528212739
  • Taylor V, McKinnon MC, Macdonald K, et al. Adults with mood disorders have an increased risk profile for cardiovascular disease within the first 2 years of treatment. Can J Psychiatry. 2010;55(6):362–368. doi:10.1177/07067437100550060520540831
  • Naiberg MR, Newton DF, Collins JE, et al. Elevated triglycerides are associated with decreased executive function among adolescents with bipolar disorder. Acta Psychiatr Scand. 2016;134(3):241–248. doi:10.1111/acps.1260327329743
  • Goldstein BI. Bipolar disorder and the vascular system: mechanisms and new prevention opportunities. Can J Cardiol. 2017;33(12):1565–1576. doi:10.1016/j.cjca.2017.10.00629173599
  • Tuomisto K, Jousilahti P, Sundvall J, Pajunen P, Salomaa V. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study. Thromb Haemost. 2006;95(3):511–518.16525580
  • Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685–1695. doi:10.1056/NEJMra04343015843671
  • Pompili M, Venturini P, Lamis DA, et al. Suicide in stroke survivors: epidemiology and prevention. Drugs Aging. 2015;32(1):21–29. doi:10.1007/s40266-014-0233-x25491561
  • Kurt E, Emul M, Ozbulut O, et al. Is valproate promising in cardiac fatal arrhythmias? Comparison of P- and Q-wave dispersion in bipolar affective patients on valproate or lithium-valproate maintenance therapy with healthy controls. J Psychopharmacol. 2009;23(3):328–333. doi:10.1177/026988110808959418515458
  • Altinbas K, Guloksuz S, Caglar IM, Caglar FN, Kurt E, Oral ET. Electrocardiography changes in bipolar patients during long-term lithium monotherapy. Gen Hosp Psychiatry. 2014;36(6):694–697. doi:10.1016/j.genhosppsych.2014.07.00125091141
  • Anticevic A, Brumbaugh MS, Winkler AM, et al. Global prefrontal and fronto-amygdala dysconnectivity in bipolar I disorder with psychosis history. Biol Psychiatry. 2013;73(6):565–573. doi:10.1016/j.biopsych.2012.07.03122980587
  • Bigger J, Fleiss JL, Rolnitzky LM, Steinman RC. The ability of several short-term measures of RR variability to predict mortality after myocardial infarction. Circulation. 1993;88:927–934.8353919
  • Kleiger RE, Miller JP, Bigger JT, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59(4):256–262. doi:10.1016/0002-9149(87)90795-83812275
  • Quintana DS, Westlye LT, Kaufmann T, et al. Reduced heart rate variability in schizophrenia and bipolar disorder compared to healthy controls. Acta Psychiatr Scand. 2016;133(1):44–52. doi:10.1111/acps.1249826371411
  • Henry BL, Minassian A, Paulus MP, Geyer MA, Perry W. Heart rate variability in bipolar mania and schizophrenia. J Psychiatr Res. 2010;44(3):168–176. doi:10.1016/j.jpsychires.2009.07.01119700172